Log in to save to my catalogue

046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyeli...

046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyeli...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2194694177

046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP)

About this item

Full title

046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP)

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A19-A19

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

Subjects

Subjects and topics

More information

Scope and Contents

Contents

IntroductionWe analysed the efficacy and safety of IVIG IgPro10 (CSL Behring) in two CIDP studies: PRIMA and PATH.MethodsPRIMA was a prospective, open-label, single-arm study in 28 CIDP patients (n=13 IVIG-pretreated; n=15 untreated) investigating efficacy and safety of IgPro10 for induction (2 g/kg) and maintenance therapy (1 g/kg every 3 weeks fo...

Alternative Titles

Full title

046 Efficacy and safety of intravenous immunoglobulin (IVIG) IGPRO10 in chronic inflammatory demyelinating polyneuropathy (CIDP)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2194694177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2194694177

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2018-ANZAN.45

How to access this item